SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-001836
Filing Date
2023-02-06
Accepted
2023-02-06 08:03:30
Documents
12
Period of Report
2023-02-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K life-20230206.htm   iXBRL 8-K 62661
  Complete submission text file 0000950170-23-001836.txt   180607

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT life-20230206.xsd EX-101.SCH 2470
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT life-20230206_pre.xml EX-101.PRE 10992
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT life-20230206_lab.xml EX-101.LAB 13352
6 EXTRACTED XBRL INSTANCE DOCUMENT life-20230206_htm.xml XML 4708
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 23588431
SIC: 2836 Biological Products, (No Diagnostic Substances)